SIDP

@SIDPharm · Geneva, IL · joined 26 Nov 2013

Official account of the Society of Infectious Diseases Pharmacists (SIDP) 🦠🧫💊 #AntimicrobialStewardship #IDX Find out more: https://t.co/grv80l08Qp

25 769Followers

2 706Following

14 973Posts total

38.7KViews on collected posts

Son gönderiler

SIDP@SIDPharm14 Sep

Don't miss out! Catch up on more landmark trials in #InfectiousDiseases this time surrounding the advancing role of oral therapy💊 📆September 30th ⏰11am CST/12pm EST 🔗 https://t.co/AaVA358CNl https://t.co/h2iquCrRDn

1.1K views · 11 likes · 4 reposts · 0 replies Open on X →

SIDP@SIDPharm11 Sep

🆕Episode of #Breakpoints: Dr. Prathit Kulkarni, lead author of a recent state-of-the-art review on acute and chronic bacterial prostatitis, joins host Dr. Erin McCreary to discuss this complex disease state. They walk through diagnosis, epidemiology, treatment, and more! https:/

0:05

1K views · 6 likes · 2 reposts · 0 replies Open on X →

SIDP@SIDPharm10 Sep

📣 Calling all ID learners! Share the podcast with your co-residents and co-fellows or anyone looking to gain more ID knowledge. Join the conversation. Tell us what ID topics you would like to be discussed on future podcast episodes. 🦠 https://t.co/KzCLpexu4J https://t.co/WGkwgHUi

929 views · 9 likes · 3 reposts · 0 replies Open on X →

SIDP@SIDPharm9 Sep

#ICYMI check out the latest Bench to Bedside with SIDP! The pipeline of gram-negative agents is expanding but where does each agent fall in therapy? Experts M. Gabriela Cabanilla, PharmD, PhC and Nardine Karam Salgado, PharmD, BCIDP discuss at 🔗 https://t.co/EE42zzhKCC https://t.

756 views · 5 likes · 1 reposts · 0 replies Open on X →

SIDP@SIDPharm9 Sep

Tell us what you are proud of! Submit your new promotion, publication, award, or innovative practice to be highlighted in the Fall SIDP newsletter! Please take 2 minutes to highlight your work: https://t.co/tdqSpE5O3H. Bookmark it to submit your accomplishments year-round 🔖 http

590 views · 1 likes · 0 reposts · 0 replies Open on X →

SIDP@SIDPharm23 Aug

@SIDPharm @ErinMcCreary They have come a long way. 151 views · 1 likes · 0 reposts · 0 replies Open on X →

SIDP@SIDPharm21 Aug

This infographic is a fantastic summary of the beta-lactamase inhibitors reviewed in the new #Breakpoints episode "Beta-lactamase inhibitors: Scientifically elegant, just complex." Use this infographic as a reference, and be sure to share! #infographic #newepisode https://t.co/v

14.2K views · 196 likes · 78 reposts · 1 replies Open on X →

SIDP@SIDPharm26 Jul 2024

It's here! 100th #Breakpoints Episode: Drs. Jeffrey Pearson & Jason Pogue join Dr. Jeannette Bouchard as they take on all things tetracyclines. Do not miss this one! This podcast was supported by an unrestricted grant from Paratek Pharmaceuticals Inc. 🎧 https://t.co/ez0n3ae0fR h

19.9K views · 72 likes · 30 reposts · 1 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 7 gönderi, 10K–100K takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha zayıf tepki.

Medyan görüntülenme929bu hesap1 01410K–100K için medyan

Erişim, %3.61%bu hesap3.74%10K–100K için medyan

Etkileşim, %0.79%bu hesap1.68%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	929	1 014	0.92×
Erişim (görüntülenme ÷ takipçi)	3.61%	3.74%	0.96×
Etkileşim oranı	0.79%	1.68%	0.47×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

19.9K26 Jul

14.2K21 Aug

15123 Aug

5909 Sep

756

92910 Sep

1K11 Sep

1.1K14 Sep

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.55%26 Jul

1.96%21 Aug

0.66%23 Aug

0.17%9 Sep

0.79%

1.29%10 Sep

0.78%11 Sep

1.32%14 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.68%.

What the audience does

Likes48.9%301 in total

Reposts19.2%118 in total

Replies0.3%2 in total

Quotes1.3%8 in total

Bookmarks30.4%187 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.